MRK Logo

Merck & Co., Inc. (MRK) 

NYSE
Market Cap
$252.61B
Sector
Healthcare
Industry
Drug Manufacturers—General
Rank in Sector
368 of 774
Rank in Industry
7 of 10

Largest Insider Buys in Sector

MRK Stock Price History Chart

MRK Stock Performance

About Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions …

Insider Activity of Merck & Co., Inc.

Over the last 12 months, insiders at Merck & Co., Inc. have bought $0 and sold $51.62M worth of Merck & Co., Inc. stock.

On average, over the past 5 years, insiders at Merck & Co., Inc. have bought $44,336 and sold $116.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 3 shares for transaction amount of $341 was made by Romanelli Joseph (President, Human Health Int?l) on 2023‑04‑26.

List of Insider Buy and Sell Transactions, Merck & Co., Inc.

2024-02-14SaleChairman, CEO & President
85,021
0.0034%
$125.40$10.66M-0.48%
2024-02-14SaleEVP & CFO
38,291
0.0015%
$125.50$4.81M-0.48%
2024-02-13SaleChairman, CEO & President
150,000
0.0059%
$125.85$18.88M-0.16%
2024-02-13SalePresident, Human Health Int?l
1,000
<0.0001%
$124.89$124,888-0.16%
2024-02-09SaleExecutive VP & President, MRL
14,702
0.0006%
$125.50$1.85M-0.13%
2024-02-07SaleEVP,Chief Info&Digital Officer
1,451
<0.0001%
$127.57$185,108-1.68%
2024-02-02SaleEVP, General Counsel
49,499
0.002%
$126.97$6.28M-0.82%
2024-02-02SaleEVP, Chief HR Officer
50,694
0.0021%
$126.65$6.42M-0.82%
2024-02-02SalePresident, U.S. Market
18,959
0.0008%
$127.17$2.41M-0.82%
2023-11-09SalePresident, U.S. Market
2,081
<0.0001%
$102.38$213,061+18.05%
2023-11-08SaleEVP&Pres, Merck Animal Heallth
43,823
0.0017%
$105.03$4.6M+15.54%
2023-08-14SaleEVP, Chief HR Officer
4,250
0.0002%
$109.01$463,293+9.17%
2023-08-03SaleEVP, Chief HR Officer
4,500
0.0002%
$105.49$474,701+12.35%
2023-08-02SalePresident, Human Health Int?l
89
<0.0001%
$107.37$9,556+12.37%
2023-05-04SaleSr. VP Fince-Global Controller
15,875
0.0006%
$117.53$1.87M-5.86%
2023-05-04SaleEVP, General Counsel
19,141
0.0008%
$117.59$2.25M-5.86%
2023-05-03SaleEVP, Chief HR Officer
53,400
0.0021%
$119.01$6.36M-6.47%
2023-05-02SaleEVP,Chief Info&Digital Officer
7,509
0.0003%
$116.82$877,222-6.21%
2023-05-01SaleEVP&Pres, Merck Animal Heallth
75,436
0.003%
$116.03$8.75M-4.96%
2023-04-28SaleChairman, CEO & President
143,329
0.0056%
$114.93$16.47M-4.38%

Insider Historical Profitability

4.24%
Romanelli JosephPresident, Human Health Int?l
19569
0.0008%
$99.8684+0.2%
HASSAN FREDChairman and CEO
720800
0.0285%
$99.8620<0.0001%
FRAZIER KENNETH CExecutive Chair
700653
0.0277%
$99.86140+21.77%
SABATINO THOMAS J JRExecutive Vice President
309535
0.0122%
$99.8610
BERTOLINI ROBERT JExecutive Vice President
65000
0.0026%
$99.8610

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$32.1B9.61243.27M-0.62%-$198.83M0.59
BlackRock$27.32B8.17207.02M+2.57%+$683.37M0.6
State Street$15.58B4.64117.43M+0.48%+$74.26M0.64
Wellington Management Company$11.39B3.4186.35M+0.88%+$99.26M1.93
Geode Capital Management$7.43B2.2356.41M+1.77%+$129.4M0.63
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.